Sprouty 2 is an independent prognostic factor in breast cancer and may be useful in stratifying patients for trastuzumab therapy

Dana Faratian, Andrew H. Sims, Peter Mullen, Charlene Kay, Inhwa Um, Simon P. Langdon, David J. Harrison

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Sprouty 2 is an independent prognostic factor in breast cancer and may be useful in stratifying patients for trastuzumab therapy'. Together they form a unique fingerprint.

Medicine and Dentistry

Biochemistry, Genetics and Molecular Biology

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology